"According to a new country report published by Lucintel, the future of the interventional cardiology and peripheral vascular device market in the United States looks promising with opportunities in hospitals and ambulatory surgical centers. The interventional cardiology and peripheral vascular device market in the United States is primarily driven by  the growing elderly population, a rise in the prevalence of chronic diseases, advancements in medical technology and research, improvement of healthcare infrastructure in developing countries, and change in lifestyles.

This report studies factors affecting the interventional cardiology and peripheral vascular device market in the United States from both demand and supply sides. The report also analyzes growth opportunities in different applications and provides comprehensive data and analysis on trends, key drivers, and directions.

By end use, the interventional cardiology and peripheral vascular device market is segmented into hospitals and ambulatory surgical centers. The hospital segment is expected to remain the largest segment in the forecast period as hospitals have a much higher budget than ambulatory surgical centers.

Emerging trends which have a direct impact on the dynamics of the interventional cardiology and peripheral vascular device industry include rising adoption of TAVR procedures, increasing use of bioresorbable stents, and a rise in adoption of drug eluting balloons.

Lucintel, a leading global strategic consulting and market research firm, has analyzed the current market trends, forecasts, new market opportunities, and competitive landscape for the interventional cardiology and peripheral vascular device market in the United States and has come up with a comprehensive research report entitled “Opportunities for the Interventional Cardiology and Peripheral Vascular Device Market in the United States.” The Lucintel report serves as a catalyst for growth strategies, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes the market size and forecast for the interventional cardiology and peripheral vascular device market in the United States by by type, device, and end use as follows:

Interventional Cardiology and Peripheral Vascular Device Market by Type [Value ($ Million) from 2014 to 2025]:
• Interventional Cardiology Device
• Peripheral Vascular Device
Interventional Cardiology and Peripheral Vascular Device Market by Device Type [Value ($ Million) from 2014 to 2025]:
• Angioplasty Balloons
• Angioplasty Stents
• Angioplasty Catheters
• EVAR stent graft
• IVC filter
• Embolic Protection Devices
• Guidewires
• Arteriotomy Closure Devices
• Intravascular Ultrasound System (IVUS)
• Synthetic Surgical Graft
Interventional Cardiology and Peripheral Vascular Device Market by End Use [Value ($ Million) from 2014 to 2025]:
• Hospitals
• Ambulatory Surgical Centers

This 60-page country research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed scope, benefits, and other details of this report, please contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/United-States/interventional-cardiology-and-peripheral-vascular-device.aspx or write to us at [email protected]

About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com "